{
    "RADCURE-2874": {
        "question": "Age: 71.7, Sex: Male, ECOG PS: ECOG 0, Smoking PY: 0, Smoking Status: Non-smoker, Ds Site: Oropharynx, Subsite: Base of Tongue, T: T1, N: N2b, M : M0, Stage: IVA, Path: Squamous Cell Carcinoma, HPV: positive, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: none, Regional: none, Distant: none, 2nd Ca: none, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-positive cases. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "Step-by-step analysis as a radiation oncologist:\n\n1. The CT scan is of the head and neck region, with two bounding boxes provided:\n   - Box 1: [257, 229, 118, 257, 263, 147]\n   - Box 2: [253, 177, 86, 253, 203, 102]\n\n2. These coordinates are normalized relative to the image size, indicating specific volumetric regions of interest (ROIs).\n\n3. From an anatomical perspective, the first bounding box appears to be located in the posterior oropharyngeal region, possibly involving the base of tongue or adjacent soft tissues. This area is a common site for HPV-related squamous cell carcinoma.\n\n4. The second bounding box is located more inferiorly and anteriorly, possibly involving lymph node regions in the neck, such as level II or III nodes, which are common sites for nodal metastases in oropharyngeal cancer.\n\n5. The presence of these ROIs suggests a primary tumor and involved nodal disease, which is critical for radiation therapy planning.\n\n6. From a radiation oncology perspective, the involvement of both primary and nodal sites indicates at least stage III or IVA disease, depending on size and number of nodes.\n\n7. HPV status is not provided here, but if positive, prognosis is generally better with radiation therapy.\n\n8. The survival probability depends on tumor size, nodal involvement, HPV status, and treatment modality.\n\n9. No obvious gross abnormalities such as bone erosion or distant metastases are described or visible in these ROIs.\n\nFinal answer: Alive",
        "initial_assessment_review_assessment-radiation oncologist": "Answer:Alive",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate_review_assessment-radiation oncologist": "Answer:no",
        "Round 2-Turn 1-ask_gap_review_assessment-radiation oncologist": "---\nAnswer: yes  \nReason: multidisciplinary input required  \n---",
        "Round 2-Turn 1-gap_identified-assistant": "- Multidisciplinary input required (implying consultation with medical oncology and possibly surgical oncology for comprehensive management)",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Medical Oncologist - Your expertise is strictly limited to systemic therapy decisions, including chemotherapy and immunotherapy in head and neck cancers. - Hierarchy: Medical Oncologist == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-medical oncologist": "Step-by-step analysis as a medical oncologist:\n\n1. The CT scan shows two masked regions of interest (ROIs) defined by the bounding boxes:\n   - Box 1: [257, 229, 118, 257, 263, 147]\n   - Box 2: [253, 177, 86, 253, 203, 102]\n\n2. These coordinates correspond to volumetric regions in the head and neck CT scan. Given the anatomical location (oropharynx, base of tongue), these ROIs likely represent the primary tumor and involved lymph nodes.\n\n3. The patient is a 71.7-year-old male with oropharyngeal squamous cell carcinoma, HPV positive, T1 primary tumor, N2b nodal involvement, and no distant metastasis (M0). The stage is IVA.\n\n4. Treatment was radiation therapy alone (70 Gy in 35 fractions), no chemotherapy.\n\n5. HPV positivity and non-smoking status are favorable prognostic factors, improving survival probability.\n\n6. N2b nodal status indicates multiple ipsilateral lymph nodes involved but no contralateral or bilateral nodes, which is intermediate risk.\n\n7. The absence of distant metastasis and good performance status (ECOG 0) also favor better outcomes.\n\n8. From the oncologic perspective, the survival probability is relatively high given HPV positivity, early T stage, and definitive radiation therapy.\n\nFinal answer:\n\nAnswer:Alive",
        "Round 2-Turn 1-gap_recruited_assessment_review_assessment-medical oncologist": "Answer:Alive",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate_review_assessment-medical oncologist": "Answer:Alive",
        "Round 2-role-comment": "radiation oncologist:alive|medical oncologist:alive",
        "Round 2-num_agents": 2,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}